USA - NYSE:ACA - US0396531008 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to ACA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-11 | DA Davidson | Maintains | Buy -> Buy |
| 2025-01-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-29 | Barclays | Initiate | Overweight |
| 2024-08-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-07 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2024-05-17 | DA Davidson | Maintains | Buy -> Buy |
| 2024-02-28 | DA Davidson | Maintains | Buy -> Buy |
| 2024-02-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-17 | Sidoti & Co. | Upgrade | Neutral -> Buy |
| 2023-08-08 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-07 | DA Davidson | Maintains | Buy -> Buy |
| 2023-08-07 | Loop Capital | Maintains | Buy -> Buy |
| 2023-05-08 | Oppenheimer | Maintains | Outperform |
| 2023-05-01 | DA Davidson | Maintains | Buy |
| 2023-05-01 | Loop Capital | Maintains | Buy |
| 2023-02-27 | DA Davidson | Maintains | Buy |
| 2022-11-08 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2022-08-08 | Stephens & Co. | Maintains | Overweight |
| 2021-11-02 | Loop Capital | Initiate | Buy |
| 2021-10-05 | Berenberg | Initiate | Buy |
| 2021-07-26 | Sidoti & Co. | Upgrade | Neutral -> Buy |
10 analysts have analysed ACA and the average price target is 118.32 USD. This implies a price increase of 16% is expected in the next year compared to the current price of 102.
The consensus rating for ARCOSA INC (ACA) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ARCOSA INC (ACA) is 10.